List of Excipients in API pirfenidone capsule, 267 mg
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing pirfenidone capsule, 267 mg
Detailed excipient profiles for pirfenidone capsule, 267 mg
Excipient focus: AMMONIA
pirfenidone capsule, 267 mg drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | pirfenidone capsule, 267 mg | 33342-461 |
| >Company | >Ingredient | >NDC |
pirfenidone capsule, 267 mg drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: BROWN IRON OXIDE
pirfenidone capsule, 267 mg drug variants containing BROWN IRON OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | pirfenidone capsule, 267 mg | 33342-461 |
| >Company | >Ingredient | >NDC |
pirfenidone capsule, 267 mg drug variants not containing BROWN IRON OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
pirfenidone capsule, 267 mg drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | pirfenidone capsule, 267 mg | 33342-461 |
| >Company | >Ingredient | >NDC |
pirfenidone capsule, 267 mg drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
pirfenidone capsule, 267 mg drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | pirfenidone capsule, 267 mg | 33342-461 |
| >Company | >Ingredient | >NDC |
pirfenidone capsule, 267 mg drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
pirfenidone capsule, 267 mg drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | pirfenidone capsule, 267 mg | 33342-461 |
| >Company | >Ingredient | >NDC |
pirfenidone capsule, 267 mg drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
pirfenidone capsule, 267 mg drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | pirfenidone capsule, 267 mg | 33342-461 |
| >Company | >Ingredient | >NDC |
pirfenidone capsule, 267 mg drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM HYDROXIDE
pirfenidone capsule, 267 mg drug variants containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | pirfenidone capsule, 267 mg | 33342-461 |
| >Company | >Ingredient | >NDC |
pirfenidone capsule, 267 mg drug variants not containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
pirfenidone capsule, 267 mg drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | pirfenidone capsule, 267 mg | 33342-461 |
| >Company | >Ingredient | >NDC |
pirfenidone capsule, 267 mg drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
pirfenidone capsule, 267 mg drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | pirfenidone capsule, 267 mg | 33342-461 |
| >Company | >Ingredient | >NDC |
pirfenidone capsule, 267 mg drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
pirfenidone capsule, 267 mg drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | pirfenidone capsule, 267 mg | 33342-461 |
| >Company | >Ingredient | >NDC |
pirfenidone capsule, 267 mg drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
pirfenidone capsule, 267 mg drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | pirfenidone capsule, 267 mg | 33342-461 |
| >Company | >Ingredient | >NDC |
pirfenidone capsule, 267 mg drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
